VASRD 7528 · Genitourinary System
Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) VA Disability Rating
This code covers malignant neoplasms of the genitourinary system — cancer of the urinary and reproductive organs rated in § 4.115b, prostate cancer among them. An active malignancy under this code is evaluated at 100 percent. Under the code's note, that 100 percent continues after surgical, X-ray, antineoplastic chemotherapy, or other therapeutic treatment ends, with a mandatory VA examination at the expiration of six months. If there has been no local recurrence or metastasis at that point, the evaluation is based on the residuals that remain, rated as voiding dysfunction or renal dysfunction, whichever is predominant.
VA Rating Tiers
| Rating | Criteria |
|---|---|
| 100% | Active GU cancer, through treatment and for six months after it ends. |
| 60% | Appliance, or pads changed more than 4 times a day. |
| 40% | Pads changed 2-4 times a day, or voiding hourly / 5+ times a night. |
| 30% | Retention needing catheterization. |
| 20% | Pads changed under twice a day, or voiding every 1-2 hours / 3-4 times a night. |
| 10% | Voiding every 2-3 hours / twice a night, or marked obstruction with an objective finding. |
| 0% | Mild obstruction needing dilation once or twice a year. |
How the VA Evaluates Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer)
The code has one criterion of its own: a malignant neoplasm of the genitourinary system is evaluated at 100 percent. Its note governs what happens afterward. The 100 percent continues following the cessation of surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure, a VA examination is mandatory at the expiration of six months, and any change in evaluation based on that or any subsequent examination is subject to § 3.105(e). Where there has been no local recurrence or metastasis, the evaluation rests on residuals under the § 4.115a formulas — voiding dysfunction or renal dysfunction, whichever is predominant. Those formulas measure concrete things: absorbent materials or an appliance and how many times a day they must be changed, daytime voiding interval and how many times a night the veteran wakes to void, urinary retention requiring intermittent or continuous catheterization and other obstructive findings, and glomerular filtration rate sustained for at least 3 consecutive months during the past 12 months.
Veterans service-connected
~6,200 veterans
Typical rating awarded
~60%
Vetrify editorial estimates informed by VA published claims data (VBA Annual Benefits Report) and the VA rating schedule — not official VA statistics.
Email me this Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) guide
Get the Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) rating criteria, evidence checklist, and strategy tips delivered to your inbox so you can review them anytime.
Best Evidence to Gather
- •Pathology and oncology records establishing the malignant neoplasm and its genitourinary site.
- •Treatment records showing the date surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure ended, which is what the six-month clock to the mandatory VA examination runs from.
- •Follow-up imaging and oncology notes addressing whether there has been local recurrence or metastasis.
- •Post-treatment urology records covering the voiding dysfunction measures — appliance or absorbent material use and changes per day, daytime voiding interval, how many times a night the veteran wakes to void, and any catheterization for urinary retention.
- •Kidney function labs including GFR values across at least 3 consecutive months, since renal dysfunction is the alternative residual formula the note names.
Strategy Tips
- •Keep the date treatment ended clearly documented — when surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure stopped — since the note sets the mandatory VA examination at the expiration of six months from that point.
- •Make sure post-treatment follow-up covers both urinary and kidney function, since the note directs the residual evaluation to voiding dysfunction or renal dysfunction, whichever is predominant, and a file documenting only one leaves that comparison unmade.
- •Have oncology follow-up records address local recurrence and metastasis explicitly, since the note makes that finding the dividing line between the 100 percent continuing and the evaluation moving to residuals.
C&P Exam Pitfalls
- •Reaching the six-month mandatory examination with no post-treatment urology or kidney workup in the file, leaving the examiner nothing to assess residuals on.
- •A record that documents the cancer treatment but never states whether there has been local recurrence or metastasis, which is the fact the note turns on.
- •Residuals documented in only one system, urinary or renal, when the note requires determining which is predominant.
- •Single GFR readings in the file, when the renal dysfunction criteria are written around values sustained for at least 3 consecutive months during the past 12 months.
Common Filing Mistakes
- •Filing only on a prostatectomy or other surgery as though the operation were the subject of this code, when the code covers malignant neoplasms of the genitourinary system and treatment is what the note's six-month sequence starts from.
- •Treating the 100 percent as permanent, when the note schedules a mandatory VA examination at the expiration of six months after treatment ends and makes any change subject to § 3.105(e).
- •Leaving post-treatment residuals undocumented and unclaimed, since after that examination the evaluation is made on residuals rated as voiding dysfunction or renal dysfunction, whichever is predominant.
Onset Patterns
- •The schedule follows a fixed sequence for this code rather than a symptom progression: an active malignancy is evaluated at 100 percent, treatment ends, the 100 percent continues, a mandatory VA examination falls at the expiration of six months, and the evaluation then rests on residuals if there has been no local recurrence or metastasis.
- •Because residuals are what the post-examination evaluation is built on, the urinary and kidney findings recorded after treatment — not the cancer diagnosis itself — determine the percentage from that point forward.
Secondary Conditions
Conditions commonly linked to Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer). Service-connecting a secondary condition can increase your combined rating.
Erectile dysfunction
Urinary incontinence
Depression
Common questions about Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer)
- Is Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) a VA-rated disability?
- Yes. The VA rates Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) under VASRD diagnostic code 7528 (Genitourinary System). This code covers malignant neoplasms of the genitourinary system — cancer of the urinary and reproductive organs rated in § 4.115b, prostate cancer among them. An activ…
- What VA disability rating can I get for Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer)?
- Possible VA ratings for Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) are 100%, 60%, 40%, 30%, 20%, 10%, 0%. Examples: 100%: Active GU cancer, through treatment and for six months after it ends.; 60%: Appliance, or pads changed more than 4 times a day.; 40%: Pads changed 2-4 times a day,…
- What's the typical VA rating awarded for Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer)?
- Vetrify estimates the typical rating awarded for Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) at around 60%, based on VA claims data and the rating schedule. An estimated 6,200 veterans are service-connected for Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer).
- What evidence helps prove Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) for VA disability?
- Strong evidence for a Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) claim includes: Pathology and oncology records establishing the malignant neoplasm and its genitourinary site.; Treatment records showing the date surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedu…
- What mistakes should veterans avoid when claiming Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer)?
- Common pitfalls when filing for Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer): Filing only on a prostatectomy or other surgery as though the operation were the subject of this code, when the code covers malignant neoplasms of the genitourinary system and treatment is what the note's six-m…
- Is Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) a presumptive condition for VA benefits?
- Yes, Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) is recognized as a presumptive condition. The VA presumes service connection if you meet the qualifying service criteria, which reduces the evidence burden compared to a direct service-connection claim.
- What conditions are commonly secondary to Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer)?
- Conditions often service-connected as secondary to Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) include: Erectile dysfunction, Urinary incontinence, Depression. Filing for secondary conditions can increase a veteran's combined VA rating.
Official sources
- 38 CFR § 4.115b — Schedule of ratings — genitourinary system (Diagnostic Code 7528)
Rating criteria on this page are an educational summary of the cited regulation — the eCFR text is authoritative. See how Vetrify derives its numbers.
Estimate your combined rating
See how Malignant Neoplasms of the Genitourinary System (Including Prostate Cancer) combines with your other service-connected conditions using the official VA combined-ratings formula.
Open the calculator
VA Calc: Disability Pay
Combine your ratings & see monthly pay on your iPhone · Works offline